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ABSTRACT
Aims We investigate the extent of and factors associatedwith denial of previously reported cannabis and other illicit drug
use, and assess the potential of hair testing for measuring substance use in general population samples. Design Birth
cohort study. Setting United Kingdom, 1991–present. Participants A total of 3643 participants who provided hair
and self-report measures of cannabis and other illicit drug use in the Avon Longitudinal Study of Parents and Children
(ALSPAC) at age 18 years. Measurements Denial of ever use of cannabis and other illicit drugs at age 18 following
previously reported use. Positive hair drug tests for cannabis and other illicit drugs, and expected numbers of false positives
and false negatives based on expected sensitivity and speciﬁcity. Findings Cannabis and other illicit drug use was
reported by 1223 and 393 individuals, respectively, before age 18 years. Of these 176 (14.4%) and 99 (25.2%),
respectively, denied use at age 18. Denial of cannabis use decreased with the reporting of other substances and antisocial
behaviour. Cannabis and other illicit drug use at age 18 was reported by 547 (22.5%) and 203 (8.4%) individuals,
respectively. Of these, 111 (20.3%) and 13 (6.4%) were hair-positive for cannabis and other illicit drugs, respectively.
Based on hair testing for cannabis use we expect 0 [95% conﬁdence interval (CI) = 0–169] false positives and
394 (95% CI = 323–449) false negatives compared to observed 362 potential false positives and 436 potential false
negatives based on self-report. In hair-positive individuals, reporting the use of other substances and antisocial behaviour
decreased the odds of a negative self-report. Conclusions Hair analysis provides an unreliable marker of substance use in
general population samples. People who report more frequent substance use before age 18 are less likely to later deny
previous substance use at age 18 than people who report occasional use.
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INTRODUCTION
Self-report is themost commonly usedmethod of collecting
substance use data. However, it is prone tomisclassiﬁcation
and could introduce bias in either direction, challenging
the credibility of substance use research [1]. Researchers
have identiﬁed the phenomenon of recanting, or the denial
of previously asserted life-time substance use [2,3]. It has
been suggested the errors encountered are less likely to
be the result of intentional distortions but rather the result
of poor comprehension, forgetting or even carelessness, as
well as age of onset of reporting [4–6]. Recanting, if not
handled carefully, is likely to have a considerable impact
upon our understanding of drug use and our efforts to pre-
vent it [2]. Knowledge of the extent and causes of under-
reporting and recanting could be used to adjust estimates
based on survey reports [7,8].
While self-report measures are used widely, there is no
true ‘gold standard’ for measuring illicit drug use (whereby
the phenomenon of recanting is just one demonstration of
the problems that can arise from using self-report mea-
sures). Finding an alternative measure of drug use that is
less prone to bias would be advantageous to epidemiologi-
cal studies. Hair analysis holds potential for application to
such studies as a biological measure of drug use. While
urine and blood samples can be used to provide a measure
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of recent drug use (2–3 days for a single use of cannabis
and up to 24 days for chronic use [9–11]), hair analysis
has a potential detection window of several months.
Furthermore, hair testing is less invasive, accepted more
readily in community settings [12] and can be stored at
room temperaturewithout the need for immediate process-
ing [13]. Fendrich and colleagues reported two main uses
of drug testing in epidemiological studies: generating accu-
rate prevalencemeasures and ‘correcting’ prevalencemea-
sures generated by self-reported information [14]. Several
studies have assessed the plausibility of using hair samples
as a replacement for urine in drug testing [15–19],
sampling individuals with higher levels of consumption
(e.g. prisoners [14], heroin overdose cases [15] and at-risk
users [19]). These results are unlikely to be applicable to
many epidemiological studies examining a general
population sample.
Using data from the Avon Longitudinal Studyof Parents
and Children (ALSPAC), we aimed to (1) investigate the ex-
tent of recanting both cannabis and other illicit drug use;
(2) assess the agreement between hair testing and self-
reported cannabis and other illicit drug use using previ-
ously reported sensitivity and speciﬁcity values to deter-
mine expected disagreement (false negative and false
positives); and (3) identify factors associated with both
recanting and self-report disagreement in positive hair test
results.
METHODS
Design
To conduct these analysis, we obtained data collected from
both questionnaires and clinic sessions in a large UK-based
birth cohort which was representative of the general popu-
lation. Data were extracted from ALSPAC, a longitudinal
study situated in Bristol, UK [20]. Full details of the
ALSPAC cohort are provided in the Supporting informa-
tion. In brief, 14541 pregnant womenwith expected deliv-
ery dates between 1 April 1991 and 31 December 1992
were recruited. These women, along with their offspring
and partners, have been followed-up ever since using both
postal questionnaires and clinic sessions. This study design
provides a large general population sample with measures
of drug use at several time-points.
Study population
This analysis utilizes data from 5217 individuals who
attended a clinic session at age 18 years
(mean = 17.8 years; range = 16.3–20.0 years). A total
of 3643 hair samples were collected from this clinic. Sam-
ples weighing less than 5 mg were excluded from analysis
(n = 563). Nineteen samples did not generate useable re-
sults when testing for 11-nor-9-carboxy-delta-9-
tetrahydrocannabinol (THC-COOH), a metabolite of can-
nabis, resulting in 3061 individuals with available hair
drug test data. Of these, 2429 (79.35%) completed the
self-report questions on cannabis use. Twelve samples did
not generate usable results when testing for other illicit
drugs and their metabolites, resulting in 3068 individuals
with available hair drug test data. Of these, 2425 (79.0%)
completed the self-report questionnaires on other illicit
drug use (Fig. 1). Other measures of drug use and covari-
ates were taken from questionnaires completed at age 14
(mean = 14.3 years; range = 14.0–16.2 years) and
17 years (mean = 16.7 years; range = 16.4–18.1 years)
and a clinic session at age 15 years (mean = 15.5 years,
range = 14.3–17.7 years).
MEASURES
Current drug use (self-reported)
Self-reported measures at age 18 years included: cannabis
use in the past 3 months (binary variable: yes/no); fre-
quency of cannabis use (categorical variable: not in the
past 3 months/monthly or less/two to four times per
month/two to three times per week/four or more times
per week); heavy cannabis use (four or more times per
week) in the past 3 months (binary variable: yes/no); and
other illicit drug use (cocaine, amphetamines, inhalants,
sedatives, hallucinogens, opioids) in the past 3 months
(binary variable: yes/no). All illicit drugs other than
cannabis were combined.
Recanting measures
In addition to the drug use measures reported above, indi-
viduals were asked about ever use of substances at age
18 years. Previously reported ever use of cannabis and
other illicit drugs was also available at ages 14, 15 and
17 years (binary variables: yes/no). Recanting was deﬁned
as denying ever use of cannabis or other illicit drug at age
18 years after reporting use at any of the earlier ages
(binary variables: not recanted/recanted use). Individuals
who had not reported use at earlier ages were excluded
from analysis.
Hair drug measures
Measures relating to the detection of cannabis (measured
using THC-COOH) and other illicit drugs (opiates, amphet-
amines, cocaine, ecstasy and their metabolites) docu-
mented the results of the hair drug testing. Detection
above cut-off values ‘conﬁrmed’ use within the past
3 months (binary variables: detected/not detected). Illicit
drugs other than cannabis were grouped together. Details
of the collection and extraction methods and cut-off values
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for hair drug testing are provided in the Supporting
information.
Covariates/predictors
Potential covariates/predictors were based on earlier anal-
yses [3,19]. This included a measure of past reported fre-
quency of cannabis or other illicit drug use at ages 14, 15
and 17 years (binary variables: used fewer than ﬁve
times/used ﬁve times or more times). Other drug use mea-
sures included measures of licit drugs collected at 18 years
[tobacco use in the past 30 days (binary variable: yes/no);
blood cotinine levels representative of smoking within the
past month using a cut-off of 10 ng/ml (these were col-
lected at the same visit as the hair sample) [21] (binary
variable: yes/no); and current alcohol use (binary variable:
non-hazardous use/hazardous or harmful use)]. Details of
the extraction methods for blood cotinine levels are pro-
vided in the Supporting information. Other measures in-
cluded: sex; familial social class (binary variable: I, II and
III non-manual/III manual, IV and V [22]); maternal edu-
cation (binary variable: CSE, vocational or O-level/A-level
or degree); GCSE English and Mathematics results (binary
variables: A*–C grade/D–U grade); depressive symptoms
using the Short Mood and Feelings Questionnaire (SMFQ)
at 18 years [dichotomized to demonstrate high
(score>11) and low (score ≤ 11) levels of depressive symp-
toms [23,24]]; self-reported antisocial behaviour in the
past year at 18 years [binary variable: no behaviours/one
or more behaviours, where behaviours are determined
using core offences in the 2005 Offending, Crime and Jus-
tice Survey (mugging, shoplifting, break and enter, selling
drugs, ﬁre-setting, selling and buying stolen goods [25])].
Statistical analyses
Individuals recanting previously reported cannabis and
other illicit drug use were compared to individuals who
did not recant use on a variety of predictors using logistic
regression. Overall agreement between hair drug testing
and self-reported use of cannabis and other illicit drugs
was assessed. Previously calculated sensitivity and speciﬁc-
ity values of hair testing for THC-COOH and other illicit
drugs were used to calculate the expected number of false
positives and negatives using the following equations:
Expected false negatives ¼ 1 sensitivityð ÞSRp
Expected false positives ¼ 1 specificityð ÞSRN
where SRP is the number of individuals with a positive self-
report of drug use and SRN is the number of individuals
with a negative self-report of drug use. This allowed for
examination of the reliability of hair drug testing to this
sample, as one would expect to ﬁnd that potential false
positives and negatives fall within the expected boundaries.
Expected false positives and negatives for THC-COOH were
calculated to compare: (a) any use in the past 3 months
with no use; and (b) heavy use in the past 3 months with
no use or light use. The sensitivity and speciﬁcity values
Figure 1 Sample derivation for analysis comparing hair drug testing and self-report data at age 18 years
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used for THC-COOH (calculated by Taylor and colleagues)
were: 0.28 [95% conﬁdence interval (CI) = 0.18–0.41]
and 1.00 (95% CI = 0.91–1.00), respectively, for compar-
ing any use in the past 3 months with no use; and 0.54
(95% CI = 0.33–0.73) and 0.95 (95% CI = 0.88–0.99),
respectively, for comparing heavy use with no use and light
use [26]. The sensitivity and speciﬁcity values used for
other illicit drugs (calculated by Ledgerwood and
colleagues) were 0.93 and 0.69, respectively (no conﬁ-
dence intervals provided) [12]. Finally, within hair-positive
individuals, we tested whether those with conﬂicting self-
report differed on a range of covariates using logistic
regression. In individuals who were hair-positive for other
illicit drugs, analyses were conducted using all available
data due to the small number of individuals who tested
hair-positive. All analyses were carried out using Stata
version 13 [27].
RESULTS
Recanting
Cannabis recanting
Ever use of cannabis was reported by 1223 individuals at
ages 14, 15 or 17 years. Of these, 176 (14.4%) did not
report ever use at age 18 and therefore recanted use.
Recanting cannabis use decreased with self-reported use
of cannabis ﬁve or more times in the past [odds ratio
(OR) = 0.24, 95% CI = 0.11–0.50, P ≤ 0.001] and with
the reporting of all other substances. Self-reported antiso-
cial behaviour at age 18 years also reduced the odds of
recanting cannabis. None of the other predictors of
recanting showed evidence of an association (Table 1).
Other illicit drug recanting
Ever use of other illicit drugs was reported by 393 individ-
uals at ages 14, 15 and 17 years. Of these, 99 (25.2%) did
not report ever use at age 18 and therefore recanted use.
The odds of recanting other illicit drug use decreased with
self-reported use of other illicit drugs ﬁve or more times in
the past (OR = 0.14, 95% CI = 0.03–0.66, P = 0.012)
and with the reporting of other substances. There was ev-
idence that individuals whose mother had a higher educa-
tionwere less likely to recant use of other illicit drugs. None
of the other predictors of recanting showed evidence of an
association (Supporting information, Table S1).
Comparison of self-report and hair testing
Seventeen different drugs/metabolites from six drug classes
were detected in at least one individual’s hair (Table 2).
Cannabis (THC-COOH)
Information on cannabis use in the past 3months was pro-
vided by 2429 individuals. Use of cannabis was reported by
547 (22.5%) individuals, 370 (67.6%) of whom reported
using cannabis monthly or less, 80 (14.6%) used two to
four times per month, 38 (6.9%) used two to three times
per week and 55 (10.1%) used four or more times per
week. Four (0.8%) did not report frequency of use. Of those
reporting cannabis use in the past 3 months 111 (20.3%)
had a positive hair test for cannabis, while 362 (19.2%) of
those not reporting use in the past 3 months had a positive
hair test (Table 3). There wasminimal change to these pro-
portions when excluding individuals withmissing informa-
tion on predictors used later in this analysis (complete case
sample) (Supporting information, Table S2).
The expected level of false positives (self-report negative
and hair-positive) and false negatives (self-report positive
and hair-negative) were 0 (95% CI = 0–169) and 394
(95% CI = 323–449), respectively, when comparing can-
nabis users with non-users. There were 362 individuals
with a positive hair test and negative self-report (i.e. poten-
tial false positives) and 436 individuals with a negative hair
test and positive self-report (i.e. potential false negatives).
Similar results were observedwhen comparing heavy users
with light users and non-users (Table 3). In individuals
who were hair-positive, those not reporting cannabis use
were less likely to report the use of other drugs, including
hazardous alcohol consumption, other illicit drugs and to-
bacco in the past 30 days, when comparedwith individuals
who did report use (Table 4). They were also less likely to
report antisocial behaviour at age 18 years. None of the
other factors showed evidence of an association
(Supporting information, Table S3).
Other illicit drug use
Illicit drug use in the past 3 months was reported by 203
(8.4%) individuals, while 2222 (91.6%) individuals re-
ported no use. A total of 32 of these individuals tested pos-
itive for illicit drugs and their metabolites in their hair. Of
those reporting use in the past 3 months, 13 (6.4%) had
a positive hair test for other illicit drugs, while 19 (0.9%)
of those not reporting use had a positive hair test (Table 3).
The expected levels of false positives and false negatives
were 156 and 63, respectively. Nineteen individuals had a
positive hair test and negative self-report (i.e. potential false
positive) and 190 individuals had a negative hair test and
positive self-report (i.e. potential false negative).
In individuals who were hair-positive, those not
reporting other illicit drug use were less likely to report
the use of other drugs, including cannabis and tobacco,
in the past 30 days compared to individuals who reported
use (Supporting information, Table S4). These individuals
were also more likely to be female and less likely to report
antisocial behaviour at 18 years. None of the other factors
showed evidence of an association (Supporting informa-
tion, Table S5).
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DISCUSSION
Approximately ~14 and ~25% of individuals who had
previously reported use of cannabis and other illicit drugs,
respectively, recanted use at age 18 years. Individuals were
less likely to recant use if they reported other drug use and
antisocial behaviours. This demonstrates that drug use
behaviours are subject to measurement error/reporting
bias, along with other behaviours that might not be
deemed ‘socially acceptable’. Individuals who reported
heavier use in the past were less likely to recant their use,
suggesting that those who ‘experiment’ once or twice with
a drug are less likely to continue reporting use later in the
life-course compared to individuals who partake in a
behaviour several times. This could be inﬂuenced by both
reporting and recall biases.
When comparing self-report with hair drug-testing
information, there were more potential false positives than
expected for the detection of cannabis and more potential
false negatives than expected for the detection of cannabis
and other illicit drugs. However, there were far fewer false
positives observed than expected (19 potential versus 190
expected) for the detection of other illicit drugs. The
number of potential false positives and negatives observed
differ from what is expected, considering the performance
of hair testing for drug use. Although there is likely to be
some disagreement between self-report and biological
measures, these ﬁndings suggest that previously reported
Table 1 Predictors of recanting use of cannabis at age 18 years using logistic regression (complete case analysis n = 546).
Covariates
Recanted cannabis use
Total N (%) OR (95% CI) PNo (n = 505) n (%) Yes (n = 41) n (%)
Sex
Male (ref) 196 (92.9) 15 (7.1) 211 (100) 1.10 (0.57–2.13) 0.778
Female 309 (92.2) 26 (7.8) 335 (100)
Past reported cannabis
use frequency
Fewer than 5 times (ref) 230 (87.8) 32 (12.2) 262 (100) 0.24 (0.11–0.50) ≤ 0.001
5 or more times 275 (96.8) 9 (3.2) 284 (100)
Alcohol consumption
Non-hazardous (ref) 182 (88.8) 23 (11.2) 205 (100) 0.44 (0.12–0.84) 0.013
Hazardous and harmful 323 (94.7) 18 (5.3) 341 (100)
Tobacco (past 30 days)
No (ref) 222 (86.7) 34 (13.3) 256 (100) 0.16 (0.07–0.37) ≤ 0.001
Yes 283 (97.6) 7 (2.4) 290 (100)
Other illicit drugs (past 3 months)
No (ref) 392 (90.7) 40 (9.3) 432 (100) 0.09 (0.01–0.64) 0.016
Yes 113 (99.1) 1 (0.9) 114 (100)
Antisocial behaviour
No (ref) 350 (90.7) 36 (9.3) 386 (100) 0.31 (0.12–0.81) 0.017
Yes 155 (96.9) 5 (3.1) 160 (100)
Social class
I, II and III non-manual (ref) 357 (93.5) 25 (6.5) 382 (100) 1.54 (0.80–2.98) 0.195
III manual, IV and V 148 (90.2) 16 (9.8) 164 (100)
Maternal education
CSE, vocational, O-level (ref) 220 (90.9) 22 (9.1) 242 (100) 0.70 (0.35–1.26) 0.213
A-level, degree 285 (93.8) 19 (6.2) 304 (100)
English GCSE
D–U (ref) 60 (90.9) 6 (9.1) 66 (100) 0.79 (0.32–1.95) 0.604
A*–C 445 (92.7) 35 (7.3) 480 (100)
Mathematics GCSE
D–U (ref) 84 (94.4) 5 (5.6) 89 (100) 1.44 (0.55–3.77) 0.462
A*–C 421 (92.1) 36 (7.90 457 (100)
SMFQ at 18 years
No (ref) 372 (92.3) 31 (7.7) 403 (100) 0.90 (0.43–1.89) 0.785
Yes 133 (93.0) 10 (7.0) 143 (100)
SMFQ (Short Moods and Feelings Questionnaire): no depressive symptoms (score ≤ 11) used as reference; GCSE = general certiﬁcate of secondary education;
OR = odds ratio; CI = conﬁdence interval.
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Table 2 Descriptive data of all drugs detected using hair analysis.
Drug class Drug/metabolite Positive cut off (ng/mg) Total (N) Detected (n) Detected (%) Range (ng/mg)
Cannabis THC-COOH 0.004 3065 627 20.5 0.004–0.05
Opiates Dihydrocodeine 0.2 919 4 0.4 0.32–31.27
Codeine 0.2 919 16 1.7 0.21–2.74
Cocaine Cocaine 0.2 904 2 0.2 0.71–55.16
Norcocaine 0.2 904 1 0.1 0.38
Benzoylecgonine 0.2 904 1 0.1 0.37
Benzodiazepines Midazolam 0.2 1043 1 0.1 0.85
Diazepam 0.2 1043 1 0.1 0.86
Oxazepam 0.2 1043 1 0.1 0.75
Alprazolam 0.2 1043 2 0.2 0.38–0.38
Desmethyldiazepam 0.2 1043 1 0.1 0.38
Methamphetamine Methamphetamine 0.2 884 6 0.7 0.22–1.22
MDA 0.2 884 2 0.2 0.21–0.29
MDEA 0.2 884 2 0.2 0.45–0.46
MBDB 0.2 884 1 0.1 0.26
MDMA 0.2 884 14 1.6 0.24–13.89
Ketamine Ketamine 0.2 870 7 0.8 0.28–20.70
Illicit drugs All including cannabis Various: see above 3068 649 21.2 NA
All excluding cannabis 0.2 3068 32 1.3 NA
Only conﬁrmation testing of each drug is shown, as there were no individuals who were detected in the screening phase without being detected in the con-
ﬁrmation stage (see hair testing methods in Supporting information). Drugs/metabolites detected in 0 individuals not shown. Opiates = morphine, A6MAM,
heroin, Acetylcodeine; amphetamine; cocaine: aeme, cocaethylene; benzodiazepines: ﬂurazepam, nitrazepam, lorazepam, temazepam, clonazepam.When ex-
cluding drugs that could be prescribed to an individual and therefore might not be used in an ‘illicit’ way, the number of individuals with other illicit drugs
detected in their hair did not change, showing that these drugs were also being used alongside other illicit substances. THC-COOH = 11-nor-9-carboxy-
delta-9-tetrahydrocannabinol; MDA = 3,4-methylenedioxyamphetamine; tenamfetamine; MDEA =3,4-methylenedioxy-N-ethyl-amphetamine; MBDB
=1,3-benzodioxolyl-N-methylbutanamine; MDMA = 3,4-methylenedioxy-methamphetamine. NA = not applicable.
Table 3 Comparison of self-report cannabis and other illicit drug measures with the detection of THC-COOH (cannabis metabolite) or
other illicit drugs (and metabolites) in hair.
Self-reported Drug use
Hair analysis
Total N (%)
Expected rates of detection using hair analysis
Not detected n (%) Detected n (%) Not detected n (95% CI) Detected n (95% CI)
Cannabis use (past 3 months)
No 1520 (80.8) 362 (19.2) 1882 (100) 1882 (1713–1882)
394 (323–449)
0 (0–169)
153 (98–224)Yes 436 (79.7) 111 (20.3) 547 (100)
Total 1956 (80.5) 473 (19.5) 2429 (100)
Heavy cannabis use (past 3 months)
No 1605 (80.8) 381 (19.2) 1986 (100) 1887 (1748–1966)
62 (36–90)
99 (20–238)
73 (45–99)Yes 104 (77.0) 31 (23.0) 135 (100)
Total 1709 (80.6) 412 (19.4) 2121 (100)
Frequency of cannabis use
Never/not in the past 3 months 1276 (80.9) 302 (19.1) 1578 (100) NA NA
Monthly or less 302 (81.6) 68 (18.4) 370 (100)
2–4 times per month 69 (86.3) 11 (13.7) 80 (100)
2–3 times per week 27 (71.1) 11 (28.9) 38 (100)
4+ times per week 35 (63.6) 20 (36.4) 55 (100)
Total 1709 (100) 412 (100) 2121 (100)
Use of other illicit drugs (past 3 months)
No 2203 (99.1) 19(0.9) 2222 (100) 2066 156
Yes 190 (93.6) 13 (6.4) 203 (100) 63 140
Total 2393 (98.7) 32 (1.3) 2425 (100)
Expected rates of detected calculated using previously reported sensitivity and speciﬁcity values for THC-COOH and other illicit drugs in hair, 95% conﬁdence
intervals calculated where possible from previously reported values. Expected rates highlighted in bold type relate to the expected numbers of false positives
and false negatives in the ALSPAC sample. THC-COOH complete case sample n= 727; other illicit drugs using all available data. Heavy cannabis use deﬁned as
weekly cannabis use (i.e. two to three times per week or four or more times per week). THC-COOH in hair compared to all self-reported cannabis variables, all
other illicit drugs and their compared to self-report other illicit drug variable. CI = conﬁdence interval; NA = not applicable.
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sensitivity values are overestimated for application to a
general population sample.
By examining the extent of recanting in a general
population sample, we have shown that self-reported
information on drug use can introduce measurement bias
(and that the bias is greater for ever use compared to
frequent use of illicit drugs). However, we have also demon-
strated that hair drug testing is unable to provide a reliable
measure of past drug use.
Limitations of this research
This analysis has the advantage of a large sample size to
examine the applicability of hair drug testing to general
population samples. None the less, several limitations
should be considered.
First, despite the large initial sample, the small num-
bers of individuals with cannabis and other illicit drugs
detected in hair leaves low power for assessment of poten-
tial reasons behind any inconsistencies. This is particu-
larly true when examining other illicit drugs, as an
initial general population sample in the thousands can re-
sult in very few individuals with drugs detected in their
hair. Secondly, different types and presentation forms of il-
licit drugs (besides combined use) show variations in time
and usage pattern [28–30]. Thus, combining the use of
‘other illicit drugs’ into one measure is a potential limita-
tion. However, due to the small number of individuals
both reporting the use of illicit drugs and with illicit drugs
detected in their hair, it would not have been possible to
examine these separately. Thirdly, while self-reported in-
formation is unlikely to provide an accurate measure of
actual exposure (e.g. strength of cannabis, how much
an individual inhales, etc.), it is the most reliable measure
of long-term drug use and can be considered a ‘gold stan-
dard’ against hair drug-testing measures. The low levels
of drug use in this general population sample suggest that
positive hair drug tests among people who do not self-
report cannabis use are more likely to be false positives
than unreported heavy cannabis use. Here, we have dem-
onstrated that individuals with a stronger drug history
are less likely to recant self-reported information, making
it appear unlikely that individuals with heavy enough
drug use to be detected are not reporting this. When ex-
amining a forensic or court sample, the opposite might
apply. Finally, THC-COOH alone was measured in hair as
a marker of cannabis use. There are other metabolites of
cannabis that can be detected in hair. While THC-COOH
in hair is less likely to be inﬂuenced by external contami-
nation and might be considered the optimal metabolite, a
previous analysis has shown that THC and cannabidiol
show greater sensitivity and speciﬁcity [26]. This analysis
could have been enhanced by testing for additional
cannabis metabolites.
Comparison with literature and implications
Percy and colleagues [3] have reported several characteris-
tics associated with recanting. The results presented here
are not consistent with those reported by Percy and
colleagues on gender (Percy suggested that women are less
likely to recant use). However, our results are consistent
when assessing other substances and antisocial behaviour.
The results in our study and that of Percy and colleagues
illustrate measurement error/reporting bias [31]. This
has wider implications for epidemiological studies on
correlates of drug use, in particular studies assessing
cannabis use (as this is often the only illicit drug whose
Table 4 Comparison of reporting licit and illicit substance use with self-reported cannabis use in individuals who had cannabis metabolite
THC-COOH detected in their hair using logistic regression (complete case analysis n = 174).
Use of other drugs
Self-reported use (past 3 months)
in those with cannabis detected in hair
Total N (%) OR (95% CI) PYes (n = 29) n (%) No (n = 145) n (%)
Alcohol consumption
Non-hazardous 4 (4.1) 93 (95.9) 97 (100) 0.08 (0.03–0.26) ≤ 0.001
Hazardous and harmful 25 (35.5) 52 (67.5) 77 (100)
Tobacco (past 30 days)
No 8 (6.0) 126 (94.0) 134 (100) 0.04 (0.02–0.12) ≤ 0.001
Yes 21 (52.5) 19 (47.5) 40 (100)
Serum cotinine (> 10 ng/ml)
No 18 (11.4) 140 (88.6) 158 (100) 0.06 (0.02–0.20) ≤ 0.001
Yes 29 (16.7) 5 (31.30 16 (100)
Other illicit drugs (past 3 months)
No 18 (11.4) 140 (88.6) 158 (100) 0.07 (0.02–0.23) ≤ 0.001
Yes 11 (68.8) 5 (31.2) 16 (100)
Allmeasures self-reported apart from serum cotinine levels. Serum cotinine cut-off level of 10 ng/ml, which is representative of smokingwithin the pastmonth
(i.e. levels higher than that observed from passive smoking). OR = odds ratio; CI = conﬁdence interval.
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use is common enough in the general population for
sample effects to be estimated). Furthermore, this analysis
has shown that individuals who report heavier cannabis
use in the past are less likely to recant their use, therefore
a measure of ever use is more likely to be misclassiﬁed
and biased than frequency of use.
Reported associations using self-reported drug use
could be attributed to measurement bias inﬂuenced by
perceptions of social desirability. Social desirability sug-
gests that individuals might under-report in order to pres-
ent themselves in a more favourable way or, conversely,
over-report to ‘show off ’. This over- or under-reporting
would be dependent upon that individual’s acceptability
of the behaviour [32]. This theory is supported by our re-
sults showing that the use of several drugs and recanting
of cannabis and other illicit drugs are associated nega-
tively. Previous literature suggests that under-reporting
varies by drug [33], with cannabis users being less likely
to under-report. Our results are in agreement with this,
with a higher percentage of ever illicit drug users
recanting use.
Two studies have assessed previously the use of hair
analysis as a biological measure of drug use in a general
population sample. Frendrich and colleagues [14] reported
higher rates of cannabis use from self-report than fromhair
testing. However, we have reported higher prevalence rates
from self-reported other illicit drug use. Ledgerwood and
colleagues [12] reported that self-report and hair testing
generally met good, but not excellent, agreement. These
previous studies had small samples sizes in their analysis
(583 and 613, respectively) in comparison to the 2452
individuals used in this study. The results reported here,
along with results published elsewhere, suggest that using
hair as a biomarker of drug use for alcohol [34], cannabis
and other illicit drugs provides a less reliable measure than
self-report data.
CONCLUSION
We have demonstrated the problem of recanting substance
use in adolescents in the general population and shown
that individuals recanting reporting are less likely to report
the use of other substances, antisocial behaviour and
depressive symptoms. However, despite the known prob-
lems with self-reported data, our ﬁndings suggest that hair
is an unreliable measure of substance use in a general
population due to many factors, among them purity of
drug consumed and differences in individuals’metabolism.
It is therefore not a viable tool in many epidemiological
studies such as cohorts.
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